Quick Answer
Decoy Therapeutics Inc. reported Research And Development Expense of $368.2 thousand for the year ending 2025.
- Decoy Therapeutics Inc. showed a decrease of -52.2% in Research And Development Expense from 2024 to 2025.
- This data is from Decoy Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: $2.80 million | Q2 2015: $3.19 million | Q3 2015: $3.45 million | Q4 2015: $3.31 million | Q1 2016: $4.39 million | Q2 2016: $6.09 million | Q3 2016: $5.67 million | Q4 2016: $4.23 million | Q1 2017: $3.91 million | Q2 2017: $4.08 million | Q3 2017: $4.74 million | Q4 2017: $4.26 million | Q1 2018: $4.68 million | Q2 2018: $6.17 million | Q3 2018: $353.6 thousand | Q4 2018: $187.8 thousand | Q1 2019: $1.7 thousand | Q2 2019: $840.1 thousand | Q3 2019: $1.14 million | Q1 2020: $1.64 million | Q2 2020: $1.44 million | Q3 2020: $1.80 million | Q1 2021: $1.74 million | Q2 2021: $2.10 million | Q3 2021: $2.02 million | Q1 2022: $4.44 million | Q2 2022: $2.92 million | Q3 2022: $3.79 million | Q1 2023: $3.73 million | Q2 2023: $2.35 million | Q3 2023: $1.04 million | Q1 2024: $243.0 thousand | Q2 2024: $214.4 thousand | Q3 2024: $137.2 thousand | Q1 2025: $75.5 thousand | Q2 2025: $116.4 thousand | Q3 2025: $61.8 thousand.
- Over the full 12 years of available data (2014 to 2025), Decoy Therapeutics Inc.'s Research And Development Expense has grown by 1,126.3%.
- Historical annual values: Fiscal year 2025: $368.2 thousand | Fiscal year 2024: $770.0 thousand | Fiscal year 2023: $7.17 million | Fiscal year 2022: $15.84 million | Fiscal year 2021: $8.55 million | Fiscal year 2020: $6.91 million | Fiscal year 2019: $4.02 million | Fiscal year 2018: $1.29 million | Fiscal year 2017: $16.99 million | Fiscal year 2016: $20.38 million | Fiscal year 2015: $12.75 million | Fiscal year 2014: $30.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: